Skip to main content
    • Aa
    • Aa

Diagnosing Symptomatic HIV-Associated Neurocognitive Disorders: Self-Report Versus Performance-Based Assessment of Everyday Functioning

  • K. Blackstone (a1), D.J. Moore (a2), R.K. Heaton (a2), D.R. Franklin (a2), S.P. Woods (a2), D.B. Clifford (a3), A.C. Collier (a4), C.M. Marra (a4), B.B. Gelman (a5), J.C. McArthur (a6), S. Morgello (a7), D.M. Simpson (a7), M. Rivera-Mindt (a7), R. Deutsch (a2), R.J. Ellis (a8), J. Hampton Atkinson (a2) and I. Grant (a2)...

Three types of HIV-associated neurocognitive disorders (HAND) exist that are distinguished by presence and severity of impairment in cognitive and everyday functioning. Although well-validated neurocognitive measures exist, determining impairment in everyday functioning remains a challenge. We aim to determine whether Self-Report measures of everyday functioning are as effective in characterizing HAND as Performance-Based measures. We assessed 674 HIV-infected participants with a comprehensive neurocognitive battery; 233 met criteria for a HAND diagnosis by having at least mild neurocognitive impairment. Functional decline was measured via Self-Report and Performance-Based measures. HAND diagnoses were determined according to published criteria using three approaches to assess functional decline: (1) Self-Report measures only, (2) Performance-Based measures only, and (3) Dual-method combining Self-Report and Performance-Based measures. The Dual-method classified the most symptomatic HAND, compared to either singular method. Singular method classifications were 76% concordant with each other. Participants classified as Performance-Based functionally impaired were more likely to be unemployed and more immunosuppressed, whereas those classified as Self-Report functionally impaired had more depressive symptoms. Multimodal methods of assessing everyday functioning facilitate detection of symptomatic HAND. Singular Performance-Based classifications were associated with objective functional and disease-related factors; reliance on Self-Report classifications may be biased by depressive symptoms. (JINS, 2012, 18, 79–88)

Corresponding author
Correspondence and reprint requests to: D.J. Moore, Department of Psychiatry, University of California, San Diego; San Diego, CA. E-mail:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

S. Albert , K. Marder , G. Dooneief , K. Bell , M. Sano , Y. Stern (1995). Neuropsychologic impairment in early HIV infection: A risk for work disability. Archives of Neurology, 52, 525530.

S. Albert , C.M. Weber , G. Todak , C. Polanco , R. Clouse , M. McElhiney , K. Marder (1999). An observed performance test of medication management ability in HIV: Relation to neuropsychological status and medication outcomes. AIDS and Behavior, 3, 121128.

A. Antinori , G. Arendt , J.T. Becker , B.J. Brew , D.A. Byrd , M. Cherner , V.E. Wojna (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69(18), 17891799.

A.T. Beck , R.A. Steer , G.K. Brown (1996). Beck Depression Inventory-Second Edition Manual. San Antonio, TX: The Psychological Corporation.

R.H.B. Benedict , J.J. Mezhir , K. Walsh , R.G. Hewitt (2000). Impact of human immunodeficiety virus type-1-associated cognitive dysfunction on activities of daily living and quality of life. Archives of Clinical Neuropsychology, 15, 535544.

M.A. Chesney , J.R. Ickovics , D.B. Chambers , A.L. Gifford , J. Neidig , B. Zwickl , A. Wu (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12(3), 255266.

L.A. Cysique , S.L. Letendre , C. Ake , H. Jin , D.R. Franklin , S. Gupta , R.L. Heaton , for the HIV Neurobehavioral Research Center group. (2011). Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China. AIDS, 24(7), 983990.

R.K. Heaton , D.B. Clifford , D.R. Franklin Jr., S.P. Woods , C. Ake , F. Vaida , I. Grant , for the CHARTER Group. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 75(23), 20872096.

R.K. Heaton , T.D. Marcotte , D.A. White , D. Ross , K. Meredith , M.J. Taylor , I. Grant (1996). Nature and vocational significance of neuropsychological impairment associated with HIV infection. The Clinical Neuropsychologist, 10(1), 114.

R.K. Heaton , M.J. Taylor , J. Manly , D.S. Tulsky (2003). Demographic effects and use of demographically corrected norms with the WAIS-III and WMS-III. In Clinical interpretation of the WAIS-III and WMS-III (pp. 181210). Burlington: Academic Press.

C.H. Hinkin , S.A. Castellon , R.S. Durvasula , D.J. Hardy , M.N. Lam , K.I. Mason , M. Stefaniak (2002). Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity. Neurology, 59(12), 19441950.

J. Hunsley , G.J. Meyer (2003). The incremental validity of psychological testing and assessment: Conceptual, methodological, and statistical issues. Psychological Assessment, 15(4), 446455.

J.A. Joska , J. Westgarth-Taylor , L. Myer , J. Hoare , K.G.F. Thomas , M. Combrinck , A.J. Flisher (2011). Characterization of HIV-associated neurocognitive disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behavior, 15, 11971203.

M. Lu , S.A. Safren , P.R. Skolnik , W.H. Rogers , W. Coady , H. Hardy , I.B. Wilson (2008). Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behavior, 12(1), 8694.

G.J. Meyer , S.E. Finn , L.D. Eyde , G.G. Kay , K.L. Moreland , R.R. Dies , G.M. Reed (2001). Psychological testing and psychological assessment. A review of evidence and issues. The American Psychologist, 56(2), 128165.

D.J. Moore , B.W. Palmer , T.L. Patterson , D.V. Jeste (2007). A review of performance-based measures of functional living skills. Journal of Psychiatric Research, 41(1-2), 97118.

S.B. Rourke , M.H. Halman , C. Bassel (1999). Neurocognitive complaints in HIV-infection and their relationship to depressive symptoms and neuropsychological functioning. Journal of Clinical and Experimental Neuropsychology, 21(6), 737756.

C.E. Schwartz , E. Kozora , Q. Zeng (1996). Towards patient collaboration in cognitive assessment: Specificity, sensitivity, and incremental validity of self-report. Annals of Behavioral Medicine, 18(2), 177184.

J.M. Simoni , A.E. Kurth , C.R. Pearson , D.W. Pantalone , J.O. Merrill , P.A. Frick (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behavior, 10(3), 227245.

A.D. Thames , B.W. Becker , T.D. Marcotte , L.J. Hines , J.M. Foley , A. Ramezani , C.H. Hinkin (2010). Depression, cognition, and self-appraisal of functional abilities in HIV: An examination of subjective appraisal versus objective performance. The Clinical Neuropsychologist, 25, 224243.

A.D. Thames , M.S. Kim , B.W. Becker , J.M. Foley , L.J. Hines , E.J. Singer , C.H. Hinkin (2010). Medication and finance management among HIV-infected adults: The impact of age and cognition. Journal of Clinical Experimental Neuropsychology, 33, 200209.

E.W. Twamley , J.M. Naraez , J.R. Sadek , D.V. Jeste , I. Grant , R.K. Heaton (2006). Work-related abilities in schizophrenia and HIV infection. Journal of Nervous and Mental Disease, 194, 268274.

Valpar International Corporation. (1986). Microcomputer Evaluation and Screening Assessment (MESA) Short Form 2. Tucson, AZ.

Valpar International Corporation. (1992). Computerized Assessment (COMPASS). Tuscon, AZ: Valpar Corporation.

G. Wagner , L.G. Miller (2004). Is the influence of social desirability on patients’ self-reported adherence overrated? Journal of Acquired Immune Deficiency Syndromes, 35(2), 203204.

S.P. Woods , D.J. Moore , E. Weber , I. Grant (2009). Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychological Review, 10, 152168.

S.P. Woods , J.D. Rippeth , A.B. Frol , J.K. Levy , E. Ryan , V.M. Soukup , R.K. Heaton (2004). Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. Journal of Clinical Experimental Neuropsychology, 26(6), 759778.

World Health Organization. (1997). Composite international diagnostic interview, version 2.1. Geneva: WHO.

R.K. Heaton , D.R. Franklin , R.J. Ellis , J.A. McCutchan , S.L. Letendre , I. Grant (2011). HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors. Journal of Neurovirology, 17(1), 316.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Journal of the International Neuropsychological Society
  • ISSN: 1355-6177
  • EISSN: 1469-7661
  • URL: /core/journals/journal-of-the-international-neuropsychological-society
Please enter your name
Please enter a valid email address
Who would you like to send this to? *